Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Oragenics Inc OGEN

Healthcare Biotechnology
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:OGEN)

Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Business Wire 5 hours ago

Oragenics, Inc. Files 10K and Provides Company Update

Business Wire April 1, 2024

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

Business Wire March 18, 2024

Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion

Business Wire March 5, 2024

Oragenics Announces Closing of Public Offering

Business Wire March 1, 2024

Oragenics Announces Pricing of Public Offering

Business Wire February 27, 2024

Oragenics Announces Proposed Public Offering

Business Wire February 27, 2024

Oragenics, Inc. Announces Leadership Transition

Business Wire February 12, 2024

Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement

Business Wire February 7, 2024
View More News ››

Opinion & Analysis (NYSEAM:OGEN)

Speculative stock picks for a scary market environment

J.W. Cotton January 29, 2010
View More Opinion ››

Bullboard Posts (NYSEAM:OGEN)

Oragenics, Inc. Announces Expiration of Its Investment Banki

JUST IN: $OGEN Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement AgreementOragenics, Inc. (NYSE American: OGEN),...
whytestocks - February 7, 2024

Oragenics, Inc. Preparing for Phase II Clinical Trials to Tr

BREAKING NEWS: $OGEN Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat ConcussionOragenics, Inc. (NYSE American: OGEN), a...
whytestocks - February 5, 2024

Oragenics Announces Termination of At-The-Market Offering Pr

NEWS: $OGEN Oragenics Announces Termination of At-The-Market Offering ProgramOragenics, Inc. (NYSE American: OGEN) (&#x201C...
whytestocks - January 23, 2024

FSD Pharma Inc is about to launch this breakthrough product

Kevin Harrington Speaks about FSD Pharma<< View Post To Watch Video >>
Peng26 - April 13, 2023

fk it mask off

thinking of the future i bought back into this one for my vaccine play, & purchased OPTI for my non vaccine play
Gonzoboardz - July 21, 2020

RE:Just bought some shares this morning

Sold all. I'll maybe buy back at $1.15
Gonzoboardz - July 14, 2020
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »